Evidence map›Paper›PMID 29702647›Full record

ArticlePLoS genetics2018

Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs.

Harley O'Connor Mount, Nicole M Revie, Robert T Todd, Kaitlin Anstett, Cathy Collins, Michael Costanzo, Charles Boone, Nicole Robbins, Anna Selmecki, Leah E Cowen

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Polyphyllin I EffectsEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. mSphere · 2020
    Article
  19. Drug resistance and tolerance in fungi.Nature reviews. Microbiology · 2020
    Review
  20. IdentifyingFrontiers in genetics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Harley O'Connor MountDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-1401-9178
Nicole M RevieDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Robert T ToddDepartment of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska, United States of America.
Kaitlin AnstettDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-6051-5503
Cathy CollinsDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Michael CostanzoDonnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
Charles BooneDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Nicole RobbinsDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Anna SelmeckiDepartment of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska, United States of America.
Leah E CowenDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-5797-0110
University of Toronto · CACreighton University · US

Funding

Mapping the reference genetic network of a eukaryotic cellR01HG005853 · NHGRI · UNIVERSITY OF TORONTO · PI ANDREWS, BRENDA JEAN, BOONE, CHARLES · 2010 to 2025
$7.6M
Systematic Analysis of Morphogenesis, Commensalism, and Virulence in a Leading Human Fungal PathogenR01AI127375 · NIAID · UNIVERSITY OF TORONTO · PI LEAH Elizabeth Cowen · 2017 to 2026
$5.3M
NHGRI NIH HHS R01 HG005853NIAID NIH HHS R01 AI127375
6 · The paper itself

Abstract

Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare curiosity to a major cause of human mortality. This is in part due to the emergence of resistance to the limited number of antifungals available to treat fungal infections. Azoles function by targeting the biosynthesis of ergosterol, a key component of the fungal cell membrane. Loss-of-function mutations in the ergosterol biosynthetic gene ERG3 mitigate azole toxicity and enable resistance that depends upon fungal stress responses. Here, we performed a genome-wide synthetic genetic array screen in Saccharomyces cerevisiae to map ERG3 genetic interactors and uncover novel circuitry important for azole resistance. We identified nine genes that enabled erg3-mediated azole resistance in the model yeast and found that only two of these genes had a conserved impact on resistance in C. albicans. Further, we screened a C. albicans homozygous deletion mutant library and identified 13 genes for which deletion enhances azole susceptibility. Two of the genes, RGD1 and PEP8, were also important for azole resistance acquired by diverse mechanisms. We discovered that loss of function of retrograde transport protein Pep8 overwhelms the functional capacity of the stress response regulator calcineurin, thereby abrogating azole resistance. To identify the mechanism through which the GTPase activator protein Rgd1 enables azole resistance, we selected for mutations that restore resistance in strains lacking Rgd1. Whole genome sequencing uncovered parallel adaptive mechanisms involving amplification of both chromosome 7 and a large segment of chromosome 3. Overexpression of a transporter gene on the right portion of chromosome 3, NPR2, was sufficient to enable azole resistance in the absence of Rgd1. Thus, we establish a novel mechanism of adaptation to drug-induced stress, define genetic circuitry underpinning azole resistance, and illustrate divergence in resistance circuitry over evolutionary time.

Indexed as

Antifungal AgentsAzolesCandida albicansDrug Resistance, FungalGTPase-Activating ProteinsHost-Pathogen InteractionsHumansMicrobial Sensitivity TestsMutationMycosesOxidoreductasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsVesicular Transport ProteinsWhole Genome SequencingAntifungal AgentsAzolesGTPase-Activating ProteinsOxidoreductasesPEP8 protein, S cerevisiaeRGD1 protein, S cerevisiaeSaccharomyces cerevisiae Proteinssterol delta-5 desaturaseVesicular Transport Proteins

Identifiers

PMID29702647
PMCPMC5922528
OpenAlexW2801204339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.